CCK-8 modulates D2 receptor agonist-induced hypermotility in the nucleus accumbens.
The influence of CCK-8 on locomotor effects associated with independent D2 receptor stimulation was studied. To selectively stimulate mesolimbic D2 receptors LY 171555 was injected into the nucleus accumbens of awake rats. Locomotor activity was measured in the open-field test. LY 171555 induced a biphasic effect: low doses stimulated, whereas higher doses inhibited locomotor activity. CCK-8 injected into the posteromedial part of the nucleus accumbens suppressed hyperlocomotion induced by LY 171555. The CCK-8 effect was prevented by the CCK-antagonist L 364,718. Our results indicate that CCK-8 modulates D2 receptor-mediated effects in the mesolimbic system.
Fink
H
H
Institute of Pharmacology and Toxicology of Charité, Humboldt-University, Berlin, GDR.
Morgenstern
R
R
Ott
T
T
D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology; D020109:Devazepide; D007267:Injections; D008297:Male; D009043:Motor Activity / Q000187:drug effects*; D009714:Nucleus Accumbens / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000502:physiology*; D017448:Receptors, Dopamine D2; D012844:Sincalide / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D001570:Benzodiazepinones; D011954:Receptors, Dopamine; D017448:Receptors, Dopamine D2; D020109:Devazepide; D012844:Sincalide